Sector Chart GT Biopharma, Inc.

Equities

GTBP

US36254L3087

Market Closed - Nasdaq 04:00:00 2024-06-18 pm EDT 5-day change 1st Jan Change
2.99 USD +2.40% Intraday chart for GT Biopharma, Inc. +0.34% -60.92%
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
6.45M - - - - -
803B
629B
351B - - - -
324B
303B